Groupe Athena, Inc. Posts Strong 1st Quarter Results, Sees Progress Toward Transition To Manufacturing
ACCESSWIRE - Mon Nov 17, 8:16AM CST
Mumbai, India / ACCESSWIRE / November 17, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) (PINKSHEETS: GATA), announced today revenues of $20,181,962 for the period ending September 30, 2014, which represents an increase of $1,419,373 over the same period in 2013. Gross income before depreciation, amortization and taxes was $1,423,850. Operating income before Depreciation and Amortization was $1,423,850 and reflects a Research and Development charge of $1,862,065.
Groupe Athena, Inc. Issues Revenue Guidance
ACCESSWIRE - Tue Sep 02, 8:19AM CDT
MUMBAI, INDIA / ACCESSWIRE / September 2, 2014 / Groupe Athena, Inc. (OTC PINK: GATA), (PINKSHEETS: GATA), announced today that based on current orders in hand they anticipate a strong first quarter and project total revenue for the period could top $20 million for the first time.
Groupe Athena, Inc. Posts Year End Financials, Betters Previous Record by 15%, Marks 5th Consecutive Double Digit Gain in Annual Revenue
ACCESSWIRE - Mon Jul 28, 3:24PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 28, 2014 / Groupe Athena, Inc. (OTC Pink: GATA) has posted the results for their fiscal year ending June 30, 2014. Annual revenue for the period was $65,189,762 which is an increase of more than 15% over the previous record fiscal year and represents an amazing 5th consecutive double digit increase in annual revenue. EBITDA for the year was also a record $10,938,698 and net after tax income for the period was $6,501,645 or $.14 per share.
Groupe Athena, Inc Sets Release Date for Year End Financials Release, Reiterates Revenue Guidance
ACCESSWIRE - Mon Jul 21, 3:20PM CDT
MUMBAI, INDIA / ACCESSWIRE / July 21, 2014 / Groupe Athena, Inc. (OTC: Pink sheets GATA) announced today they will release their financial results for the fiscal year ended June 30, 2014 after the close of the market on July 28.
Auxilium Pharmaceuticals, Inc. To Present At The Barclay's Global Healthcare Conference
PR Newswire - Tue Mar 04, 5:30AM CST
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a fully integrated specialty biopharmaceutical company, today announced that certain members of the executive management team will participate in the Barclay's Global Healthcare Conference to be held March 11-13, 2014 at the Loews Hotel in Miami. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product portfolio at 3:45 p.m. ET on Tuesday, March 11, 2014.
AUXL: 34.40 (+0.18)